Literature DB >> 186155

Free amino acids and related substances in human glial tumours and in fetal brain: comparison with normal adult brain.

J M Lefauconnier, C Portemer, F Chatagner.   

Abstract

An ion exchange automatic chromatographic analysis of the free amino acid concentrations of 18 human glial tumours and of 4 human fetal brains was carried out and the concentrations were compared to those of 13 biopsy specimens of normal adult brain. In addition, the concentrations of the amino acids of the glial tumours were compared to those of 7 intracerebral metastases of various origin. The chromatograms of several tumour specimens showed an unidentified peak overlapping proline. As far as the amino acid concentrations are concerned they varied depending upon the origin of the sample. The concentrations of most amino acids were higher in fetal brain than in adult brain with the exception of aspartic acid, glutamic acid, glutamine, cystathionine and GABA. Two peptides: glutathione and homocarnosine were absent in fetal brain and were present in adult brain. In glial tumours, homocarnosine and some amino acids, namely aspartic acid, glutamic acid and GABA, showed lower concentrations than in normal brain. Some amino acids were in the same concentration as in normal brain: taurine, phosphoethanolamine, glutamine and cystathionine. Most of the others were in higher concentrations than in normal brain, mainly proline. The results suggest that the concentrations of 5 compounds: taurine, proline, cystathionine, GABA and homocarnosine, taken as a whole, provide information on the origin of the sample.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186155     DOI: 10.1016/0006-8993(76)90559-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  In vivo 1 H MRS detection of cystathionine in human brain tumors.

Authors:  Francesca Branzoli; Dinesh K Deelchand; Marc Sanson; Stéphane Lehéricy; Małgorzata Marjańska
Journal:  Magn Reson Med       Date:  2019-05-26       Impact factor: 4.668

2.  Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment.

Authors:  Lu-Lin Jiang; Bing Zhu; Yingjun Zhao; Xiaoguang Li; Tongfei Liu; Juan Pina-Crespo; Lisa Zhou; Wenxi Xu; Maria J Rodriguez; Haiyang Yu; Don W Cleveland; John Ravits; Sandrine Da Cruz; Tao Long; Dongxian Zhang; Timothy Y Huang; Huaxi Xu
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

3.  A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death.

Authors:  Michael R Freeman; Jayoung Kim; Michael P Lisanti; Dolores Di Vizio
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

4.  Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.

Authors:  Francesca Branzoli; Clément Pontoizeau; Lucien Tchara; Anna Luisa Di Stefano; Aurélie Kamoun; Dinesh K Deelchand; Romain Valabrègue; Stéphane Lehéricy; Marc Sanson; Chris Ottolenghi; Małgorzata Marjańska
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

Review 5.  Proline Metabolism in Malignant Gliomas: A Systematic Literature Review.

Authors:  Magdalena M Sawicka; Karol Sawicki; Tomasz Łysoń; Barbara Polityńska; Wojciech Miltyk
Journal:  Cancers (Basel)       Date:  2022-04-17       Impact factor: 6.575

6.  Cystathionine in rat brain: catabolism in vivo.

Authors:  J M Lefauconnier; C Portemer; F Chatagner
Journal:  Neurochem Res       Date:  1978-06       Impact factor: 3.996

Review 7.  Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile.

Authors:  Francesca Branzoli; Małgorzata Marjańska
Journal:  Curr Opin Neurol       Date:  2020-08       Impact factor: 6.283

Review 8.  Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?

Authors:  Jan Lewerenz; Pamela Maher
Journal:  Front Neurosci       Date:  2015-12-16       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.